Desq Long
Sign in

Company

Bolt Biotherapeutics, Inc.

BOLT · CIK 0001641281

Sign in to watch
SEC FORM 4
$29,554.80

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 9,132 shares at $3.2364 per share.

Reporting Person Quinn William P. · Officer Title President, CEO and CFO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

SEC FORM 4
$13,194.80

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 4,077 shares at $3.2364 per share.

Reporting Person Nemec Sarah · Officer Title Senior VP, Finance and PAO · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →

SEC FORM 4
$22,169.34

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 6,850 shares at $3.2364 per share.

Reporting Person Yonehiro Grant · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396894 · filed 2026-09-21 · View filing →

SEC FORM 4
$21,718.27

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 6,545 shares at $3.3183 per share.

Reporting Person Quinn William P. · Officer Title President, CEO and CFO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

SEC FORM 4
$9,696.07

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 2,922 shares at $3.3183 per share.

Reporting Person Nemec Sarah · Officer Title Senior VP, Finance and PAO · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →

SEC FORM 4
$16,289.53

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 4,909 shares at $3.3183 per share.

Reporting Person Yonehiro Grant · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001193125-26-396894 · filed 2026-09-21 · View filing →

SEC FORM 4
$7,129.09

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 1,889 shares at $3.7740 per share.

Reporting Person Quinn William P. · Officer Title President, CEO and CFO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 21, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

SEC FORM 4
$3,181.48

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 843 shares at $3.7740 per share.

Reporting Person Nemec Sarah · Officer Title Senior VP, Finance and PAO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 21, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →

SEC FORM 4
$5,347.76

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 1,417 shares at $3.7740 per share.

Reporting Person Yonehiro Grant · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 21, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001193125-26-396894 · filed 2026-09-21 · View filing →

SEC FORM 4CLUSTER · 2 INSIDERS
$4,441.89

Bolt Biotherapeutics, Inc. (BOLT)

Purchase of 1,146 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Quinn William P., President, CEO and CFOPurchase of 637 shares at $3.876 per share.$2,469.01
  • Nemec Sarah, Senior VP, Finance and PAOPurchase of 509 shares at $3.876 per share.$1,972.88

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Jun 5, 2026 · Disclosed Sep 21, 2026FILED +108 DAYS

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

Source: SEC Form 4 · 0001193125-26-396892 · filed 2026-09-21 · View filing →

Permalink →